Rochford Rosemary, Moormann Ann M
Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY, USA.
Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA, 01605, USA.
Curr Top Microbiol Immunol. 2015;390(Pt 1):267-85. doi: 10.1007/978-3-319-22822-8_11.
Endemic Burkitt's lymphoma (BL) remains the most prevalent pediatric cancer in sub-Saharan Africa even though it was the first human cancer with a viral etiology described over 50 years ago. Epstein-Barr virus (EBV) was discovered in a BL tumor in 1964 and has since been implicated in other malignancies. The etiology of endemic BL has been linked to EBV and Plasmodium falciparum malaria co-infection. While epidemiologic studies have yielded insight into EBV infection and the etiology of endemic BL, the modulation of viral persistence in children by malaria and deficits in EBV immunosurveillance has more recently been reified. Renewed efforts to design prophylactic and therapeutic EBV vaccines provide hope of preventing EBV-associated BL as well as increasing the ability to cure this cancer.
尽管地方性伯基特淋巴瘤(BL)是50多年前描述的第一种具有病毒病因的人类癌症,但它仍然是撒哈拉以南非洲最常见的儿童癌症。1964年在一例BL肿瘤中发现了爱泼斯坦-巴尔病毒(EBV),此后它也与其他恶性肿瘤有关。地方性BL的病因与EBV和恶性疟原虫的共同感染有关。虽然流行病学研究已经深入了解了EBV感染和地方性BL的病因,但疟疾对儿童病毒持续性的调节以及EBV免疫监视缺陷最近得到了证实。重新努力设计预防性和治疗性EBV疫苗为预防EBV相关的BL以及提高治愈这种癌症的能力带来了希望。